Neumora Therapeutics, Inc. — 10-Q Filings
7 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Neumora Therapeutics, Inc. (NMRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. Neumora Therapeutics, Inc. has filed 7 10-Q documents with the SEC since 2021. To view all SEC filings by Neumora Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
8-A12B
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
PRE 14A
S-1
S-1/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-269446 | Nov 6, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-104138 | Aug 6, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-069311 | May 12, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-125437 | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-091737 | Aug 6, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-054448 | May 7, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-057424 | Nov 1, 2023 | Sep 30, 2023 |